Funder: METAvivor
Due Dates: August 20, 2025 (Internal) | December 30, 2025 (Full application)
Funding Amounts: $200,000 total over 2 years; one application per applicant
Summary: Supports translational and clinical research to improve quality of life or mitigate side effects for individuals with metastatic breast cancer, requiring meaningful patient advocate involvement.
Key Information: Applications must propose mechanism-based interventions and include patient advocate participation in both application and project phases.